Arab Press

بالشعب و للشعب
Wednesday, Dec 24, 2025

Dr. Sanjay Gupta on medical marijuana: We are in an age of wisdom, but also an age of foolishness

We have made great strides with medical marijuana, but we've also repeated some of the same mistakes that led cannabis to be vilified and misunderstood in the first place. Hype and echo chambers are never a friend to science or clear-eyed thinking.

When we released "Weed" in 2013, few people had ever heard of cannabidiol, or CBD. Now, two-thirds of Americans are familiar with the compound, and 1 in 7 have tried it. Most of the country, 93%, are in favor of medical marijuana and hemp-derived CBD itself, which has less than 0.3% THC, has been legalized in every state.

It's not just public perception. The science over the last six years has grown by leaps and bounds, as well. Epidiolex, a pharmaceutical-grade CBD oil, went through clinical trials and is being prescribed for thousands of patients with seizures. The founder of GW Pharmaceuticals, the maker of Epidiolex, told me they are now developing cannabis medications for everything from autism to anxiety.

The lives of characters we introduced you to in "Weed" have completely changed, as well. The Stanley brothers of Colorado - who literally bet the farm on CBD and couldn't even afford a reliable car six years ago - now grow CBD on 800 acres in three states and have a marijuana empire worth an estimated $2 billion.

And Charlotte, sweet Charlotte Figi. Soon after birth, she started having seizures. By age 3, she was having 300 seizures a week, despite having tried more than half a dozen medications. Her mother, Paige, worried her daughter would stop breathing one day or go into cardiac arrest. Charlotte was not expected to live past her 8th birthday. Today, she's 12, and has only two or three seizures a month, despite being off all of her other seizure medications. The only thing she takes is a CBD oil, called Charlotte's Web. She represents countless patients who are alive today because of this plant, and this plant alone.

For many in the medical marijuana community, these last few years have been the realization of a dream they never really believed was possible. But, there is a funny thing about dreams. As beautiful as they are, they are often fragile and ready to tear at the seams.

Here is where the cannabis story took an awkward, ill-conceived and sometimes ugly turn.


A bold promise, hijacked

Last year, in a single moment, the legislation around CBD, a non-psychoactive component of cannabis, changed. With the passage of the Farm Bill, hemp, defined as any cannabis plant with 0.3% THC or less, became legal to grow, sell, and consume. For the cannabis community, it was like suddenly drinking from a fire hose in the middle of a drought. One day, it was taboo wrapped in decades of stigma, and now it is sold at the corner store.

There are CBD-infused oils, mints, cheeseburgers, vitamin waters, shampoos and even sportswear. Most of this stuff couldn't possibly offer the human body any benefit. Without the respect of being treated like the medicine it is, or reasonable regulation when it is purchased as a supplement, CBD has been hijacked by unscrupulous actors peddling crooked, corrupt and contaminated products. They're making a quick buck and disappearing into the ether without a trace.

It was really discouraging to see the results of a recent study in the medical journal JAMA where researchers analyzed 84 CBD products from 31 companies and found 69% were mislabeled. Some of the products had no CBD at all, some had too much CBD, some too much THC.

Others studies showed that some CBD products contained dangerous synthetics that have been responsible for outbreaks of illness all over the country. The legitimate vendors of CBD, who took the time to ensure consistency, safety and quality, are now sadly lumped together with the dishonest and dodgy ones, leaving the consumer confused about where to turn.

The general attitude we have long heard from CBD consumers is they think the product "might help, can't hurt, why not." But, when you can't even count on the authenticity or safety of the product you are buying, that is no longer the case.

In our latest investigation, "Weed 5: The CBD Craze," we take you on board the cannabis rocket ship, that shot us from a barren wasteland of prohibition to the Wild West of the CBD craze, and we reveal exactly how we got here. We also provide a roadmap to help you navigate the landscape of CBD, including understanding how to read a "certificate of analysis" and determining what is legal and what isn't.


A story of facts, not faith

With the release of my first "Weed" documentary and op-ed in 2013, some say I became an advocate for medical marijuana. At first I recoiled. To me and my journalist friends and colleagues, "advocacy" can be a dirty word. No doubt, it is sometimes necessary, to champion causes that would otherwise get little attention. To some, however, advocacy implies a certain lack of objectivity, a blind faith. Is that what happened with "Weed"?

There's one thing I can't stress enough: The core story of cannabis has never required me or anyone else to follow blindly. With medical marijuana, you aren't asked to sacrifice your objectivity or your skepticism. You too will discover it if you diligently study the evidence from all over the world, spend days in the lab to really understand the cannabis molecules - and visit patients whose lives truly depend on it.

The real story of cannabis has always been rooted in facts, not faith.

With the series of "Weed," films, I wanted to shine a light on what would have been obvious, if people had taken the time to look. Echo chambers exist, even in the world of science. I wanted to show you that these chambers can grow bigger and louder with each generation that neglects to challenge them. For too long, the real story of cannabis was drowned out in those echo chambers. Marijuana was preordained as having "no currently accepted medical use and a high potential for abuse" despite plenty of evidence to the contrary. My team and I wanted you to hear the other side, the voices that had been drowned out by decades of this noise.


Let science lead the way

Over the last six years, I have continued to read constantly, discuss the latest scientific developments with researchers and spend hours with patients to really understand their experience with cannabis as a medication. Through it all, however, there has been something else nagging at me.

I realized that CBD has become such a convenient political narrative, so easy to rally behind. Maybe too easy.

Indeed, CBD alone doesn't make you high. You don't have to smoke it. And the people it has helped the most are little kids like Charlotte. But that was never supposed to be the entire story. After all, "Weed" wasn't just about CBD, it was about weed, the entire cannabis plant, comprised of hundreds of potentially therapeutic ingredients. And yes, one of those is THC, which to this day remains demonized with the rest of the cannabis plant as a federally illegal (Schedule 1) substance, even though it too has shown promise as an effective medicine.

We are in an age of wisdom, but also an age of foolishness. We have made great strides with medical marijuana, but we've also repeated some of the same mistakes that led cannabis to be vilified and misunderstood in the first place. Hype and echo chambers are never a friend to science or clear-eyed thinking.

Make no mistake: Cannabis is a medicine. Over the last six years, through countless articles and essays, and now five documentary films, my team and I have made that case and we have provided the proof. At times, it can heal when nothing else can. Denying people this substance represents a moral issue just as much as a medical one.

I have always let science and facts lead the way. That isn't advocacy; that is speaking truth to power. But yes, when you are certain of the evidence and people's lives depend on it, then shout it from the rooftops, trumpet it loudly in medical conferences and make sure the world knows. If being called an advocate means you took the time to faithfully learn the issues, allowed yourself to change and even admit where you were wrong, then I will proudly own the title and honorably wear the badge.

Newsletter

Related Articles

Arab Press
0:00
0:00
Close
Saudi Arabia’s 2025: A Pivotal Year of Global Engagement and Domestic Transformation
Saudi Arabia to Introduce Sugar-Content Based Tax on Sweetened Drinks from January 2026
Saudi Hotels Prepare for New Hospitality Roles as Alcohol Curbs Ease
Global Airports Forum Highlights Saudi Arabia’s Emergence as a Leading Aviation Powerhouse
Saudi Arabia Weighs Strategic Choice on Iran Amid Regional Turbulence
Saudi Arabia Condemns Sydney Bondi Beach Shooting and Expresses Solidarity with Australia
Washington Watches Beijing–Riyadh Rapprochement as Strategic Balance Shifts
Saudi Arabia’s Vision 2030 Drives Measurable Lift in Global Reputation and Influence
Alcohol Policies Vary Widely Across Muslim-Majority Countries, With Many Permitting Consumption Under Specific Rules
Saudi Arabia Clarifies No Formal Ban on Photography at Holy Mosques for Hajj 2026
Libya and Saudi Arabia Sign Strategic MoU to Boost Telecommunications Cooperation
Elon Musk’s xAI Announces Landmark 500-Megawatt AI Data Center in Saudi Arabia
Israel Moves to Safeguard Regional Stability as F-35 Sales Debate Intensifies
Cardi B to Make Historic Saudi Arabia Debut at Soundstorm 2025 Festival
U.S. Democratic Lawmakers Raise National Security and Influence Concerns Over Paramount’s Hostile Bid for Warner Bros. Discovery
Hackers Are Hiding Malware in Open-Source Tools and IDE Extensions
Traveling to USA? Homeland Security moving toward requiring foreign travelers to share social media history
Wall Street Analysts Clash With Riyadh Over Saudi Arabia’s Deficit Outlook
Trump and Saudi Crown Prince Cement $1 Trillion-Plus Deals in High-Profile White House Summit
Saudi Arabia Opens Alcohol Sales to Wealthy Non-Muslim Residents Under New Access Rules
U.S.–Saudi Rethink Deepens — Washington Moves Ahead Without Linking Riyadh to Israel Normalisation
Saudi Arabia and Israel Deprioritise Diplomacy: Normalisation No Longer a Middle-East Priority
As Trump Deepens Ties with Saudi Arabia, Push for Israel Normalization Takes a Back Seat
Thai Food Village Debuts at Saudi Feast Food Festival 2025 Under Thai Commerce Minister Suphajee’s Lead
Saudi Arabia Sharpens Its Strategic Vision as Economic Transformation Enters New Phase
Saudi Arabia Projects $44 Billion Budget Shortfall in 2026 as Economy Rebalances
OPEC+ Unveils New Capacity-Based System to Anchor Future Oil Output Levels
Hong Kong Residents Mourn Victims as 1,500 People Relocated After Devastating Tower Fire
Saudi Arabia’s SAMAI Initiative Surpasses One-Million-Citizen Milestone in National AI Upskilling Drive
Saudi Arabia’s Specialty Coffee Market Set to Surge as Demand Soars and New Exhibition Drops in December
Saudi Arabia Moves to Open Two New Alcohol Stores for Foreigners Under Vision 2030 Reform
Saudi Arabia’s AI Ambitions Gain Momentum — but Water, Talent and Infrastructure Pose Major Hurdles
Tensions Surface in Trump-MBS Talks as Saudi Pushes Back on Israel Normalisation
Saudi Arabia Signals Major Maritime Crack-Down on Houthi Routes in Red Sea
Italy and Saudi Arabia Seal Over 20 Strategic Deals at Business Forum in Riyadh
COP30 Ends Without Fossil Fuel Phase-Out as US, Saudi Arabia and Russia Align in Obstruction Role
Saudi-Portuguese Economic Horizons Expand Through Strategic Business Council
DHL Commits $150 Million for Landmark Logistics Hub in Saudi Arabia
Saudi Aramco Weighs Disposals Amid $10 Billion-Plus Asset Sales Discussion
Trump Hosts Saudi Crown Prince for Major Defence and Investment Agreements
Families Accuse OpenAI of Enabling ‘AI-Driven Delusions’ After Multiple Suicides
Riyadh Metro Records Over One Hundred Million Journeys as Saudi Capital Accelerates Transit Era
Trump’s Grand Saudi Welcome Highlights U.S.–Riyadh Pivot as Israel Watches Warily
U.S. Set to Sell F-35 Jets to Saudi Arabia in Major Strategic Shift
Saudi Arabia Doubles Down on U.S. Partnership in Strategic Move
Saudi Arabia Charts Tech and Nuclear Leap Under Crown Prince’s U.S. Visit
Trump Elevates Saudi Arabia to Major Non-NATO Ally Amid Defense Deal
Trump Elevates Saudi Arabia to Major Non-NATO Ally as MBS Visit Yields Deepened Ties
Iran Appeals to Saudi Arabia to Mediate Restart of U.S. Nuclear Talks
Musk, Barra and Ford Join Trump in Lavish White House Dinner for Saudi Crown Prince
×